STOCK TITAN

[DEFA14A] Sonim Technologies, Inc. Additional Proxy Soliciting Materials

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
DEFA14A
Rhea-AI Filing Summary

VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.

Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (≈0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.

VirnetX Holding Corp. (VHC) ha presentato un modulo Form 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali legati a precedenti assegnazioni di azioni vincolate. La nota esplicativa conferma che la transazione riguarda esclusivamente il regolamento fiscale e non implica una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta è pari a 31.848 azioni e quella indiretta a 11.278 azioni detenute tramite The Short Revocable Living Trust, mantenendo sostanzialmente invariata l’esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti strumenti derivati e non sono state comunicate altre attività interne. Data la dimensione irrilevante (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica un cambiamento nel sentimento interno verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 informando una transacción automática y no discrecional por parte del Científico Jefe Robert D. Short III el 07/07/2025. La compañía retuvo 50 acciones ordinarias (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones de nómina e impuestos relacionados con premios de acciones restringidas previamente otorgadas. La nota explicativa confirma que la transacción es exclusivamente para liquidación fiscal y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y la indirecta de 11,278 acciones mantenidas a través de The Short Revocable Living Trust, dejando la exposición económica total de Short prácticamente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se revelaron otras actividades internas. Dado el tamaño insignificante (≈0.1 % del total de participaciones de Short) y su naturaleza administrativa, la presentación tiene significado limitado para la inversión y no señala un cambio en el sentimiento interno hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50주 보통주 (거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 세금 정산을 위한 것임을 명확히 하며 공개 시장 판매는 포함되지 않는다고 밝혔습니다.

거래 후 소유 지분은 직접 보유 주식 31,848주와 The Short Revocable Living Trust를 통해 보유한 간접 주식 11,278주로, Short의 전체 경제적 노출은 본질적으로 변함이 없습니다. 파생 증권의 행사, 취득 또는 처분은 없었으며, 다른 내부자 활동도 공개되지 않았습니다. 규모가 미미(Short 총 보유량의 약 0.1%)하고 행정적 성격임을 고려할 때, 이번 보고는 투자에 미치는 영향이 제한적이며 VirnetX에 대한 내부자의 심리 변화는 나타내지 않습니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction automatique et non discrétionnaire d’initié réalisée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code de transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction sert strictement au règlement fiscal et n’implique pas une vente sur le marché ouvert.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initié n’a été divulguée. Compte tenu de la taille insignifiante (≈0,1 % du total des avoirs de Short) et de sa nature administrative, ce dépôt présente une signification limitée pour les investisseurs et ne signale aucun changement de sentiment interne envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommensteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die erläuternde Anmerkung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien über The Short Revocable Living Trust, wodurch seine wirtschaftliche Gesamtexponierung im Wesentlichen unverändert bleibt. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insideraktivitäten wurden offengelegt. Aufgrund der unbedeutenden Größe (≈0,1 % von Shorts Gesamtbestand) und administrativen Natur hat die Meldung begrenzte investitionsrelevante Bedeutung und signalisiert keine Änderung der Insider-Stimmung gegenüber VirnetX.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Only 50 shares withheld for taxes; negligible impact and neutral signal.

The Code F designation reveals an automatic share surrender to cover tax obligations on vested stock, a routine event that does not reflect a discretionary buy or sell decision. Post-withholding, the insider still controls roughly 43 k shares, indicating sustained alignment with shareholders. Because the transaction involves less than 1 % of his position and no derivatives, liquidity or valuation impact is essentially nil. From a governance and sentiment perspective, the filing is neutral; it neither strengthens nor weakens the investment case for VHC.

VirnetX Holding Corp. (VHC) ha presentato un modulo Form 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali legati a precedenti assegnazioni di azioni vincolate. La nota esplicativa conferma che la transazione riguarda esclusivamente il regolamento fiscale e non implica una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta è pari a 31.848 azioni e quella indiretta a 11.278 azioni detenute tramite The Short Revocable Living Trust, mantenendo sostanzialmente invariata l’esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti strumenti derivati e non sono state comunicate altre attività interne. Data la dimensione irrilevante (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica un cambiamento nel sentimento interno verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 informando una transacción automática y no discrecional por parte del Científico Jefe Robert D. Short III el 07/07/2025. La compañía retuvo 50 acciones ordinarias (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones de nómina e impuestos relacionados con premios de acciones restringidas previamente otorgadas. La nota explicativa confirma que la transacción es exclusivamente para liquidación fiscal y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y la indirecta de 11,278 acciones mantenidas a través de The Short Revocable Living Trust, dejando la exposición económica total de Short prácticamente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se revelaron otras actividades internas. Dado el tamaño insignificante (≈0.1 % del total de participaciones de Short) y su naturaleza administrativa, la presentación tiene significado limitado para la inversión y no señala un cambio en el sentimiento interno hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50주 보통주 (거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 세금 정산을 위한 것임을 명확히 하며 공개 시장 판매는 포함되지 않는다고 밝혔습니다.

거래 후 소유 지분은 직접 보유 주식 31,848주와 The Short Revocable Living Trust를 통해 보유한 간접 주식 11,278주로, Short의 전체 경제적 노출은 본질적으로 변함이 없습니다. 파생 증권의 행사, 취득 또는 처분은 없었으며, 다른 내부자 활동도 공개되지 않았습니다. 규모가 미미(Short 총 보유량의 약 0.1%)하고 행정적 성격임을 고려할 때, 이번 보고는 투자에 미치는 영향이 제한적이며 VirnetX에 대한 내부자의 심리 변화는 나타내지 않습니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction automatique et non discrétionnaire d’initié réalisée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code de transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction sert strictement au règlement fiscal et n’implique pas une vente sur le marché ouvert.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initié n’a été divulguée. Compte tenu de la taille insignifiante (≈0,1 % du total des avoirs de Short) et de sa nature administrative, ce dépôt présente une signification limitée pour les investisseurs et ne signale aucun changement de sentiment interne envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommensteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die erläuternde Anmerkung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien über The Short Revocable Living Trust, wodurch seine wirtschaftliche Gesamtexponierung im Wesentlichen unverändert bleibt. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insideraktivitäten wurden offengelegt. Aufgrund der unbedeutenden Größe (≈0,1 % von Shorts Gesamtbestand) und administrativen Natur hat die Meldung begrenzte investitionsrelevante Bedeutung und signalisiert keine Änderung der Insider-Stimmung gegenüber VirnetX.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

 

Filed by the Registrant ☒

 

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement
   
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
Definitive Proxy Statement
   
Definitive Additional Materials
   
Soliciting Material under §240.14a-12

 

Sonim Technologies, Inc.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

 

ISS Recommends Sonim Technologies Stockholders to Vote “FOR” Company Nominees on the WHITE Proxy Card

 

ISS Underscores Orbic’s Months of Unreasonable Demands and Incomplete Offers

 

July 11, 2025 7:30 AM EDT | Source: Sonim Technologies, Inc.

 

San Diego, California—(Newsfile Corp. - July 11, 2025) - Sonim Technologies, Inc. (NASDAQ: SONM), a leading provider of rugged mobile solutions, today announced that Institutional Shareholder Services (ISS) has recommended that Sonim stockholders vote “FOR” four of the Company’s nominees on the WHITE proxy card ahead of the Company’s upcoming Annual Meeting of Stockholders on July 18, 2025. ISS is the global leader in independent shareholder meeting research and issues voting recommendations on more than 50,000 shareholder meetings annually.

 

In its July 10, 2025, report1, ISS determined that Orbic North America, LLC (“Orbic”) has failed to make a compelling case for change and that the Sonim Board’s response to Orbic is appropriate:

 

“The board’s response to date appears appropriate…[T]here are still uncertainties [with Orbic’s latest offer] and the dissident’s approach to this campaign provides a reasonable basis for the board to remain wary. Given these factors, the dissident has not made a case that change is needed at the board level.”

 

Notably, specific to Orbic’s unsolicited acquisition proposals, ISS emphasized several concerns:

 

“However, when considered in the proper context, it appears that the board has a reasonable basis for being wary of the dissident. It is important to establish at the outset that there have been concerns with the dissident’s approach at nearly every step of its campaign. The dissident began by demanding that leadership immediately resign and hand over control to Orbic. From there, the dissident presented offers that failed to provide a reasonable level of certainty. It took multiple rejections from the board before the dissident presented a financing commitment.”
“This approach [by Orbic] is difficult to understand, particularly when one considers factors such as the dissident’s preexisting knowledge of the company, the duration of the dissident’s takeover attempt (approximately five months elapsed from the first suggestion of a board overhaul to the provision of a financing commitment), and the fact that the board was publicly pursuing other transactions. Even the dissident’s most recent offer is strained by contingencies. For instance, the offer expired less than a week after it was presented.”
“Instead of presenting an offer that established clarity on key terms and provided a suitable level of certainty, the dissident spent months presenting SONM with unreasonable demands and incomplete offers. Even the dissident’s most recent offer, which includes a financing commitment, is strained by contingencies and contains ambiguities about valuation.”

 

The Sonim Board made the following statement regarding ISS’s recommendation:

 

“The Sonim Board is delighted that ISS has recommended stockholders to vote for our nominees at next week’s Annual Meeting. We are particularly pleased that ISS also saw through Orbic’s distractions and tactics.

 

 

1 Permission to use quotes neither sought nor obtained. Emphasis added.

 

 

 

 

“As we have maintained, Orbic’s unfunded and baseless proposal amounts to nothing more than hype with no substance. After months of requests, Orbic has shown zero evidence of the proof of readily available and unconditional funds. Orbic’s financing ‘Commitment Letter’ is in fact not a commitment to finance. It is a commitment to attempt to raise money without an obligation to do so. It is not proof of funds or an approved credit facility or lender. Their ‘third party lender’ categorizes itself as a placement agent that will solicit debt financing after due diligence.

 

“We urge all Sonim stockholders to join ISS in seeing through Orbic’s tactics and protect their investment.”

 

For more information or assistance with voting your shares, please call the Company’s proxy solicitor:

 

Sodali & Co

430 Park Avenue, 14th Floor,

New York, NY 10022

Banks and Brokers Call: (203) 658-9400

Stockholders Call Toll Free: (800) 662-5200

E-mail: SONM@investor.sodali.com

 

About Sonim Technologies

 

Sonim Technologies is a leading U.S. provider of rugged mobile solutions, including phones, wireless internet data devices, accessories and software designed to provide extra protection for users that demand more durability in their work and everyday lives. Trusted by first responders, government, and Fortune 500 customers since 1999, we currently sell our ruggedized mobility solutions through tier one wireless carriers and distributors in North America, EMEA, and Australia/New Zealand. Sonim devices and accessories connect users with voice, data, workflow and lifestyle applications that enhance the user experience while providing an extra level of protection. For more information, visit www.sonimtech.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements relate to, among other things, the outcome of negotiations with Orbic and the search for strategic alternatives by the Special Committee, Sonim’s ability to enter strategic transactions with potential counterparties, perceived benefits of the strategic alternatives favored by Sonim’s board of directors, and the Special Committee’s assessments in connection with the search for strategic alternatives. These forward-looking statements are based on Sonim’s current expectations, estimates and projections about its business and industry, management’s beliefs and certain assumptions made by Sonim, all of which are subject to change. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “achieve,” “aim,” “ambitions,” “anticipate,” “believe,” “committed,” “continue,” “could,” “designed,” “estimate,” “expect,” “forecast,” “future,” “goals,” “grow,” “guidance,” “intend,” “likely,” “may,” “milestone,” “objective,” “on track,” “opportunity,” “outlook,” “pending,” “plan,” “poised,” “position,” “possible,” “potential,” “predict,” “progress,” “promises,” “roadmap,” “seek,” “should,” “strive,” “targets,” “to be,” “upcoming,” “will,” “would,” and variations of such words and similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. Factors that may cause actual results to differ materially include, but are not limited to, the following: the ability of Sonim to meet expectations regarding the timing and completion of the proposed transaction; the possibility that the letter of intent (LOI) will not result in the definitive agreement; the possibility that the conditions to the closing of the proposed transaction are not satisfied, including the risk that the required approvals are not obtained and that Sonim’s stockholders do not approve the proposed transaction; the occurrence of any event, change or other circumstances that could result in the definitive agreement (if ever executed) being terminated or the proposed transaction not being completed on the terms reflected in the definitive agreement, or at all; the risk that the LOI may be terminated in circumstances that require Sonim to pay a termination fee; potential litigation relating to the proposed transaction; the risk that the proposed transaction and its announcement could have adverse effects on the market price of Sonim’s common stock; risk that the current board of directors of Sonim loses proxy contest and the new directors’ slate determines to terminate the proposed transaction (whether at the state of LOI or definitive agreement); risks related to the possible failure of Sonim to achieve earn-out; the effect of the announcement of the proposed transaction on the ability of Sonim to retain key personnel and maintain relationships with customers and business partners; the risk of unexpected costs or expenses resulting from the proposed transaction and the LOI; and other risks and uncertainties, including those described under “Risk Factors” included in Sonim’s most recent Annual Report on Form 10-K and any subsequent quarterly filings on Form 10-Q filed with the Securities and Exchange Commission (available at www.sec.gov). Sonim cautions you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Sonim assumes no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, except as required by law.

 

 

 

 

Important Information and Where to Find It

 

Sonim has filed with the SEC a definitive proxy statement on Schedule 14A, containing a form of WHITE proxy card, with respect to its solicitation of proxies for the 2025 Annual Meeting of Stockholders.

 

Sonim’s stockholders are strongly encouraged to read Sonim’s definitive proxy statement (including any amendments or supplements thereto) and any other documents to be filed with the SEC carefully and in their entirety when they become available because they will contain important information.

 

Stockholders may obtain a free copy of the definitive proxy statement, any amendments or supplements to the proxy statement, and other documents that Sonim files with the SEC at no charge from the SEC’s website at www.sec.gov. Copies will also be available at no charge on Sonim’s website at https://ir.sonimtech.com/sec-filings/all-sec-filings.

 

Participants in Solicitation

 

Sonim and its respective directors, executive officers, and other members of their management and employees, including Peter Liu (Chief Executive Officer and a director), Clay Crolius (Chief Financial Officer), and Sonim’s directors - James Cassano, Mike Mulica, Jack Steenstra, and Jeffrey Wang - under SEC rules, may be deemed to be participants in the solicitation of proxies of Sonim’s stockholders in connection with the election of directors at Sonim’s 2025 Annual Meeting and related proposals to Sonim’s stockholders.

 

Stockholders may obtain more detailed information regarding Sonim’s directors and executive officers, including a description of their direct or indirect interests, by security holdings or otherwise, under the captions “Directors, Executive Officers, and Corporate Governance ,” “Security Ownership of Certain Beneficial Owners and Management ,” and “Certain Relationships and Related Party Transactions ” of Sonim’s definitive proxy statement for the 2025 Annual Meeting filed with the SEC on June 18, 2025.

 

To the extent holdings of our directors and executive officers reported in the definitive proxy statement change, such changes will be reflected on Statements of Change in Ownership on Forms 3, 4 or 5 filed with the SEC, if and when they become available. These documents will be available free of charge as described above.

 

Additional Information and Where to Find It

 

This communication relates to the proposed transaction involving Sonim. This communication does not constitute a solicitation of any vote or approval. In connection with the proposed transaction, Sonim plans to file with the SEC a proxy statement (the “Proxy Statement”) relating to a special meeting of its stockholders and may file other documents with the SEC relating to the proposed transaction, including a prospectus. This communication is not a substitute for the Proxy Statement or any other document that Sonim may file with the SEC or send to its stockholders in connection with the proposed transaction. Before making any voting decision, stockholders of Sonim are urged to read the Proxy Statement in its entirety when it becomes available and any other relevant documents filed or to be filed with the SEC and any amendments or supplements thereto and any documents incorporated by reference therein, because they will contain important information about the proposed transaction and the parties to the proposed Transaction. Any vote in respect of resolutions to be proposed at a stockholder meeting of Sonim to approve the proposed transaction or related matters, or other responses in relation to the proposed transaction, should be made only on the basis of the information contained in the Proxy Statement. Investors and security holders will be able to obtain the Proxy Statement and other documents Sonim files with the SEC (when available) free of charge at the SEC’s website (http://www.sec.gov) or at Sonim’s investor relations website (https:// https://ir.sonimtech.com/) or by e-mailing Sonim to ir@sonimtech.com.

 

Media Contact:

 

Anette Gaven

Anette.Gaven@sonimtech.com

1-619-993-3058

 

SOURCE: Sonim Technologies, Inc.

 

 

 

 

 

 

 

 

 

 

FAQ

What did VirnetX (VHC) disclose in the latest Form 4?

The company reported that Chief Scientist Robert D. Short III had 50 shares withheld on 07/07/2025 to cover tax obligations.

Was the 50-share transaction an open-market sale of VHC stock?

No. The shares were automatically withheld by VirnetX for taxes (Transaction Code F), not sold on the open market.

How many VirnetX shares does Robert D. Short III hold after the transaction?

He owns 31,848 shares directly and 11,278 shares indirectly via The Short Revocable Living Trust.

Did the filing report any derivative securities activity?

No derivative securities were acquired, exercised, or disposed of in this Form 4.

What is the investment significance of this Form 4 for VHC shareholders?

The filing is largely administrative; the small tax-withholding action does not indicate a change in insider sentiment or company outlook.
Sonim Technologies Inc

NASDAQ:SONM

SONM Rankings

SONM Latest News

SONM Latest SEC Filings

SONM Stock Data

12.17M
13.08M
62%
1.53%
1.01%
Communication Equipment
Telephone & Telegraph Apparatus
Link
United States
SAN DIEGO